Novel Tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline Chalcones Suppress Breast Carcinoma through Cell Cycle Arrests and Apoptosis
Molecules · 2023
DOI: 10.3390/molecules28083338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Mahmoud I M Darwish und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt. Hauptthemen laut MEDLINE: Chalcones, Chalcone, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chalcones are interesting anticancer drug candidates which have attracted much interest due to their unique structure and their extensive biological activity. Various functional modifications in chalcones have been reported, along with their pharmacological properties. In the current study, novel chalcone derivatives with the chemical base of tetrahydro-[1,2,4]triazolo[3,4-a]isoquinolin-3-yl)-3-arylprop-2-en-1-one were synthesized, and the structure of their molecules was confirmed through NMR spectroscopy. The antitumor activity of these newly synthesized chalcone derivatives was tested on mouse (Luc-4T1) and human (MDA-MB-231) breast cancer cell lines. The antiproliferative effect was evaluated through SRB screening and the MTT assay after 48 h of treatment at different concentrations. Interestingly, among the tested chalcone derivatives, chalcone analogues with a methoxy group were found to have significant anticancer activity and displayed gradient-dependent inhibition against breast cancer cell proliferation. The anticancer properties of these unique analogues were examined further by cytometric analysis of the cell cycle, quantitative PCR, and the caspases-Glo 3/7 assay. Chalcone methoxy derivatives showed the capability of cell cycle arrest and increased Bax/Bcl2 mRNA ratios as well as caspases 3/7 activity. The molecular docking analysis suggests that these chalcone methoxy derivatives may inhibit anti-apoptotic proteins, particularly cIAP1, BCL2, and EGFRK proteins. In conclusion, our findings confirm that chalcone methoxy derivatives could be considered to be potent drug candidates against breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt.
- Department of Comparative and Experimental Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
- Zoology Department, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt.
- Animal Health Research Institute, Agriculture Research Center, Giza 12619, Egypt.
- National Gene Bank of Egypt, Giza 12916, Egypt.
- Molecular Physiology Division, Faculty of Science, Beni-Suef University, Beni-Suef 62511, Egypt.
ORCID-Profile: Mohamed Mansour, Abdelfatteh El Omri, Hossam H Shawki, Ismail A Abdelhamid, Hisashi Oishi
Zitieren
APA
Darwish, M. I. M., Moustafa, A. M., Youssef, A. M., Mansour, M., Yousef, A. I., El Omri, A., Shawki, H. H., Mohamed, M. F., Hassaneen, H. M., Abdelhamid, I. A., & Oishi, H. (2023). Novel Tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline Chalcones Suppress Breast Carcinoma through Cell Cycle Arrests and Apoptosis. Molecules. https://doi.org/10.3390/molecules28083338
Vancouver
Darwish MIM, Moustafa AM, Youssef AM, Mansour M, Yousef AI, El Omri A, et al. Novel Tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline Chalcones Suppress Breast Carcinoma through Cell Cycle Arrests and Apoptosis. Molecules. 2023. doi:10.3390/molecules28083338
BibTeX
@article{Darwish2023,
author = {Darwish, Mahmoud I M and Moustafa, Ahmed M and Youssef, Asmaa M and Mansour, Mohamed and Yousef, Ahmed I and El Omri, Abdelfatteh and Shawki, Hossam H and Mohamed, Magda F and Hassaneen, Hamdi M and Abdelhamid, Ismail A and Oishi, Hisashi},
title = {Novel Tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline Chalcones Suppress Breast Carcinoma through Cell Cycle Arrests and Apoptosis},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28083338}
}
EUVIMED